EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy and Durability of the Association of Botox and Skinvive in the Treatment of Moderate/Severe Wrinkles in the Periorbital Region: A Randomized, Controlled, Double‐Blind, Split‐Face Clinical Study

Maria Luiza Boechat Borges Neves, Cecilia Thome, Silvio Ventura da Silva Junior, Thalita Machado, Alfonso Sánchez-Ayala, Mariana Barbosa Câmara-Souza, Giancarlo De la Torre Canales iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70403 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Maria Luiza Boechat Borges Neves und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Ingá University Center, Paraná, Brazil. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Hyaluronic Acid, Dermal Fillers. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The combined efficacy and durability of botulinum toxin A (BTX) and hyaluronic acid fillers (HA) for canthal wrinkles have not been thoroughly evaluated in randomized clinical trials.

Aims

This study evaluated the efficacy, safety, and durability of the combined treatment protocol of onabotulinumtoxinA and Juvederm Volite VYC‐12 (Skinvive) for moderate and severe canthal lines.

Methods

This randomized double‐blinded split‐face trial included 25 women with periorbital dynamic wrinkles at severity levels II–IV according to the Merz 5‐point scale. After bilateral onabotulinummtoxinA injections, the sides of the participants' faces were randomized to receive HA injections or a simulated injection. Assessed variables included electromyography activity (EMG), Merz 5‐point crow's feet scale, and FACE‐Q appraisal on crow's feet lines. Assessments were performed at baseline, 1, 2, 3, and 6 months. For differences in EMG and satisfaction scores, the two‐way repeated measures ANOVA and Bonferroni's post hoc analyses were conducted. Wrinkle severity scores were analyzed with the Mann–Whitney U test.

Results

Inter‐treatment comparisons revealed no significant differences between treatment protocols in all assessed periods for EMG ( p = 0.86). For severity of canthal wrinkles, onabotulinumtoxinA + VYC‐12 exhibited lower canthal wrinkle severity in rest and contracted positions after 3 ( p = 0.04), and 3 ( p = 0.007) and 6 ( p = 0.001) months, respectively. Additionally, satisfaction with BTX‐HA treatment was significantly higher after 3‐month ( p = 0.001) and 6‐month ( p = 0.001) follow‐ups compared to BTX treatment.

Conclusions

Higher improvements in canthal wrinkles could be enhanced by using onabotulinumtoxinA and VYC‐12 in association as a treatment protocol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ASkin AgingHyaluronic AcidDermal FillersCosmetic TechniquesNeuromuscular AgentsHumansFemaleDouble-Blind MethodMiddle AgedTreatment OutcomeAdultPatient SatisfactionSeverity of Illness IndexElectromyographyFace

Stichwörter der Autor:innen

Canthal wrinklesVYC‐12botulinum toxin type ahyaluronic acid filleronabotulinumtoxinA

Substanzen

Botulinum Toxins, Type AHyaluronic AcidDermal FillersNeuromuscular Agentsonabotulinum toxin A

Autor:innen und Institutionen

  • Department of Dentistry, Ingá University Center, Paraná, Brazil.
  • Private Practice, Paraná, Brazil.
  • Department of Dentistry, University of Ponta Grossa, Paraná, Brazil.
  • Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health and Science, Almada, Portugal.
  • Division of Oral Rehabilitation, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.

ORCID-Profile: Giancarlo De la Torre Canales

Zitieren

APA

Neves, M. L. B. B., Thome, C., da Silva Junior, S. V., Machado, T., Sánchez-Ayala, A., Câmara-Souza, M. B., & De la Torre Canales, G. (2025). Efficacy and Durability of the Association of Botox and Skinvive in the Treatment of Moderate/Severe Wrinkles in the Periorbital Region: A Randomized, Controlled, Double‐Blind, Split‐Face Clinical Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70403

Vancouver

Neves MLBB, Thome C, da Silva Junior SV, Machado T, Sánchez-Ayala A, Câmara-Souza MB, et al. Efficacy and Durability of the Association of Botox and Skinvive in the Treatment of Moderate/Severe Wrinkles in the Periorbital Region: A Randomized, Controlled, Double‐Blind, Split‐Face Clinical Study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70403

BibTeX
@article{Neves2025,
  author = {Neves, Maria Luiza Boechat Borges and Thome, Cecilia and da Silva Junior, Silvio Ventura and Machado, Thalita and Sánchez-Ayala, Alfonso and Câmara-Souza, Mariana Barbosa and De la Torre Canales, Giancarlo},
  title = {Efficacy and Durability of the Association of Botox and Skinvive in the Treatment of Moderate/Severe Wrinkles in the Periorbital Region: A Randomized, Controlled, Double‐Blind, Split‐Face Clinical Study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70403}
}
Kostenlos starten →